DA approves non-opioid painkiller Journavx, but long-term solution remains elusive Pharmaceuticals February 1, 2025 While Journavx marks progress in non-opioid pain treatment, its modest effectiveness highlights the ongoing challenge of finding alternative pain relief solutions.